Egyptian Society of Liver Cancer
1 clinical trials · Sponsor
◉ Watch Egyptian Society of Liver Cancer
| Record | Firm | Date |
|---|---|---|
| Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE (NCT01539018) | Egyptian Society of Liver Cancer | 2012-01-01 |
Track Egyptian Society of Liver Cancer automatically
Every clearance here is in the API, with alerts when new ones post.